BioVendor is a European pharmaceutical technology company that focuses on providing in vitro research products for molecular and cellular laboratories. Its main products include recombinant proteins, antibodies, and ELISA kits. At present, the company is committed to research on the utilization of hormones and cytokines, with product related directions including energy metabolism and weight regulation; Bone metabolism; Cardiovascular disease and kidney disease; Infection and inflammation; Iron metabolism research; Muscle growth control; Damage markers of neural tissue; Oncology; Pancreatic regulatory molecules; Secretory phospholipase A2, etc.
